These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2493092)

  • 1. Clinical and biological features in the 12 months preceding onset of AIDS in HIV-infected subjects.
    Lefrere JJ; Courouce AM; Lambin P; Fine JM; Doinel C; Salmon C
    J Acquir Immune Defic Syndr (1988); 1989; 2(1):100-1. PubMed ID: 2493092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection.
    Rinaldo C; Kingsley L; Neumann J; Reed D; Gupta P; Lyter D
    J Clin Microbiol; 1989 May; 27(5):880-4. PubMed ID: 2501352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study.
    Sei Y; Tsang PH; Roboz JP; Sarin PS; Wallace JI; Bekesi JG
    J Clin Immunol; 1988 Nov; 8(6):464-72. PubMed ID: 3146584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of serum HIV-Ag related to the major core protein (p24) in persons at risk for AIDS.
    Borghi V; De Rienzo B; Pietrosemoli P; Pecorari M; Mongiardo N; Pellegrino F; Zanchetta GP; Lami G; Squadrini F
    Microbiologica; 1989 Jan; 12(1):81-3. PubMed ID: 2497304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against the major core protein p24 of human immunodeficiency virus: relation to immunological, clinical and prognostic findings.
    Lindhardt BO; Gerstoft J; Hofmann B; Pallesen G; Mathiesen L; Dickmeiss E; Ulrich K
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):614-9. PubMed ID: 2506021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus (HIV) infection in haemophiliacs: long-term prognostic significance of the HIV serologic pattern.
    Raska K; Kim HC; Raska K; Martin E; Raskova J; Saidi P
    Clin Exp Immunol; 1989 Jul; 77(1):1-6. PubMed ID: 2504517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients.
    McHugh TM; Stites DP; Busch MP; Krowka JF; Stricker RB; Hollander H
    J Infect Dis; 1988 Nov; 158(5):1088-91. PubMed ID: 3141521
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
    Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
    Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative western immunoblotting analysis in survey of human immunodeficiency virus-seropositive patients.
    Schiavini DG; Puel JM; Averous SA; Bazex JA
    J Clin Microbiol; 1989 Sep; 27(9):2062-6. PubMed ID: 2506222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of virus isolation and antigen enzyme immunoassay in the detection of HIV].
    Barrett PN; Dorner F; Stingl G; Heinz FX; Kunz C
    Wien Klin Wochenschr; 1989 Jun; 101(13):446-7. PubMed ID: 2503943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significance.
    Allain JP; Laurian Y; Einstein MH; Braun BP; Delaney SR; Stephens JE; Daluga CK; Dahlen SJ; Knigge KM
    Blood; 1991 Mar; 77(5):1118-23. PubMed ID: 1671648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
    Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the presence of P24 antigen in persons with antibodies to human immunodeficiency virus in Spain.
    Leal M; Pineda JA; Calderón EJ; Rey C; Lissen E
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):244-8. PubMed ID: 2496994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients.
    Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
    J Infect Dis; 1995 Sep; 172(3):897-8. PubMed ID: 7658093
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.
    Jiang JD; Chu FN; Naylor PH; Kirkley JE; Mandeli J; Wallace JI; Sarin PS; Goldstein AL; Holland JF; Bekesi JG
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):382-90. PubMed ID: 1372353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24.
    Schmidt G; Amiraian K; Frey H; Wethers J; Stevens RW; Berns DS
    J Clin Microbiol; 1989 May; 27(5):843-8. PubMed ID: 2501350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional study of immunologic abnormalities in intravenous drug abusers on methadone maintenance in New York City.
    Grieco MH; Reddy MM; Fusillo CA; Sorrell SJ; Buimovici-Klein E; Gindi EJ; Brown DK; Saxinger WC; Weiss SH; Flaster ER
    AIDS; 1989 Apr; 3(4):235-7. PubMed ID: 2500957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.